Oncoinvent presents a unique opportunity to join an expanding pharmaceutical start-up with both R&D and production established in-house which enables both hands-on lab work as well as working with external partners.
The company has solid owners and is in a clinical phase with its lead product (Radspherin®) which is produced in Nydalen.
The candidates should be looking for the energy in a start up with the ambition to make a difference. Successful candidates should be flexible, team-oriented yet able to work independently, and be analytical and results oriented.
If you would like to send us an open application, please send your application and résumé to oncoinvent@oncoinvent.com
Oncoinvent AS is looking for a production technician to strengthen the production team at the company’s manufacturing facility in Oslo. The production team at Oncoinvent is tasked with the development, and GMP compliant production of radiopharmaceuticals. The position is an exciting opportunity to work in an innovative and dynamic start-up company and participate in the development of novel pharmaceuticals.
Oncoinvent AS Gullhaugveien 7 0484 Oslo Norway
Oncoinvent AS is looking for a production technician to strengthen the production team at the company’s manufacturing facility in Oslo. The production team at Oncoinvent is tasked with the development, and GMP compliant production of radiopharmaceuticals. The position is an exciting opportunity to work in an innovative and dynamic start-up company and participate in the development of novel pharmaceuticals.
The successful candidate will, together with the production team and other Oncoinvent staff, drive the manufacture and development of Radspherin® for pre-clinical and early-phase clinical trials.
This position requires work with radioactive materials. A successful candidate is therefore expected to comply with radiation protection and other health and safety procedures during laboratory- and production scale experiments, and GMP production activities.
Key responsibilities:
Qualifications and experience:
The holder of this position should have the following documented qualifications and experience:
The following experience is desirable:
Location
The holder of this position will be based at Oncoinvent AS, Gullhaugveien 7, 0484 Oslo. The position will report to the Head of Production.
Application deadline
We are reviewing the applications on a rolling basis.
About Oncoinvent
Oncoinvent is a privately held Norwegian company based in Nydalen, Oslo. The company is committed to developing novel, innovative products to provide better treatment options for cancer patients.
The Oncoinvent team consists of 46 employees and the company anticipates further growth.
Oncoinvent holds a state-of-the-art manufacturing facility to produce drug products intended for use in pre-clinical and clinical trials. Clinical trials for Oncoinvent’s lead product, Radspherin® are ongoing. For further details on Oncoinvent see www.oncoinvent.com.
The facility holds a GMP certificate from the Norwegian Medical Agency. The approval provides the company with the necessary flexibility and capacity for manufacturing clinical trial material for both patients and trial sites, as well as developing the company further.
The company’s lead product candidate Radspherin® is a novel alpha-emitting radioactive microsphere suspension designed for treatment of micro-metastatic cancers in body cavities. The radium-224 based therapeutic, Radspherin® has shown strong and consistent anticancer activity at doses being essentially non-toxic in preclinical studies. It is anticipated that the product can potentially treat several forms of micro-metastatic cancer.
The development programs of the pipeline of the company include targeted radionuclide therapy for treatment of various solid cancers. The main focus of discovery is on alpha-emitting radionuclides for treatment by regional administration of the drug in body compartments with disseminated solid tumours.
Contact:
Bjørn Fuglaas, 90775752
CEO
Life Science Partners AS
alfheim@oncoinvent.com
+47 464 40 045
Jan A. Alfheim is a business executive with over thirty years’ experience bringing product ideas and technology to the chemical and pharmaceutical markets, from product concept inception through discovery and development phases to final marketing campaign and launch.
With experience in research, project management, business development & partnering, company start-ups, and product launches, Alfheim comes from Nordic Nanovector ASA where he was Chief Executive Officer from 2011 until 2014 and Chief Operating Officer from 2014 to 2016. Prior to working at Nordic Nanovector, he has held various senior roles including Chief Business Officer at Clavis Pharma, President of StemPath Inc, Director of Business Development at Neurochem Inc and Project Director at Nycomed Imaging. Mr. Alfheim holds a MSc from Concordia University and a MBA from McGill University.